Tawnes, Judy Ann D.

HRN: 29-06-62  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/27/2026
AMPICILLIN 1GM (VIAL)
05/27/2026
05/28/2026
IV
2 G
Q6
PROM
Checking Initial Appropriateness 
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/27/2026
IV
2g
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness 
05/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2026
05/27/2026
IV
1g
PTOR
Pre Op Prophylaxis
Checking Initial Appropriateness 
05/27/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/27/2026
05/28/2026
IV
500mg
Q8hr X 6 Doses
Sp PLTCS, THICKLY MSAF
Checking Initial Appropriateness 
05/27/2026
CEFAZOLIN 1GM (VIAL)
05/27/2026
05/28/2026
IV
2g
Q8hr X 6 Doses
SP PLTCS ; THICKLY MSAF
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: